Medicines Evaluation Unit Ltd

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• COPD2 trials
• Idiopathic pulmonary fibrosis1 trial

Phase

• Phase 12 trials
• Phase 1/21 trial

Status

• Completed3 trials

Lead sponsor

• AeroRx Therapeutics Inc.2 trials
• Trevi Therapeutics1 trial

Closed trials

• Completed

  Phase 1 PK Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients

  NCT07802730· Phase 1· AeroRx Therapeutics Inc.· Source

• Completed

  NAL ER IPF Respiratory Function and Safety Study

  NCT07036029· Phase 1· Trevi Therapeutics· Source

• Completed

  Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD

  NCT06841640· Phase 1/2· AeroRx Therapeutics Inc.· Source